persistent mullerian duct syndrome

per·sis·tent mül·le·ri·an duct syn·drome

familial disorder with presence of fallopian tube, uterus, and testis in a male. Deficient müllerian inhibitory substance secondary to Sertoli cell defect. Synonym(s): hernia uteri inguinale

persistent müllerian duct syndrome

A rare form of male pseudohermaphroditism of childhood onset, which is characterised by persistence of müllerian duct (“female”) structures in a phenotypically normal male.

Clinical findings
Cryptorchidism, testicular hypoplasia, normal virilisation at puberty, increased testicular tumours and transverse testicular ectopia.

单词	persistent mullerian duct syndrome
释义	DictionarySeesyndrome persistent mullerian duct syndrome per·sis·tent mül·le·ri·an duct syn·drome familial disorder with presence of fallopian tube, uterus, and testis in a male. Deficient müllerian inhibitory substance secondary to Sertoli cell defect. Synonym(s): hernia uteri inguinale persistent müllerian duct syndrome A rare form of male pseudohermaphroditism of childhood onset, which is characterised by persistence of müllerian duct (“female”) structures in a phenotypically normal male. Clinical findings Cryptorchidism, testicular hypoplasia, normal virilisation at puberty, increased testicular tumours and transverse testicular ectopia. AcronymsSeePMDS
随便看	carcinoembryonic antigen carcinoembryonic antigen (cea) carcinoembryonic antigen peptide-1 carcinoembryonic antigen test carcinoembryonic gene member 2 carcinogen carcinogen assessment group carcinogene carcinogenesis carcinogenesis and toxicologic evaluation branch carcinogenic carcinogenic activity indicator carcinogenic assessment group carcinogenicity carcinogenic, mutagenic or toxic to reproduction carcinogenic polycyclic aromatic hydrocarbon carcinogenic potency carcinogenic potency database carcinogenic potency factor carcinogenic potency project carcinogenic risk assessment verification endeavor carcinogenic risk in occupational settings carcinogenic slope factor carcinogen identification committee carcinogens